DAVID WOMBLE: Open Payments
NPI 1225494800 · WESLACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,740 in 74 payments from 9 companies in 2025. Trend: 2023 $63 · 2024 $1,228 · 2025 $1,740
Food & beverage: $1,740
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 20 | $770 |
| Amgen Inc. | 15 | $282 |
| Novo Nordisk Inc | 14 | $230 |
| Lilly USA, LLC | 13 | $118 |
| Otsuka America Pharmaceutical, Inc. | 1 | $115 |
| Novartis Pharmaceuticals Corporation | 5 | $111 |
| PFIZER INC. | 3 | $55 |
| Exact Sciences Corporation | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
Products named: FREESTYLE LIBRE 3, REXULTI, OTEZLA, Wegovy, Ozempic, MOUNJARO, LEQVIO, EVENITY.
Industry payments across TX — which companies pay providers there.
